Therapeutics

151 trials 76 recruiting

Filter these 151 trials by phase, country and sponsor.

Open in Search →

CoCroS trial Ended

2024-516002-33-01 Crohn's disease 6 2019-12-23
Phase III randomised trial evaluating chemotherapy early treatment intensification with temozolomide in adults present with a glioblastoma Ended

2022-500451-23-00 Adults with a de novo glioblastoma 5 2019-03-18
Maintaining or Stopping immunosuppressive Therapy in patients with ANCA vasculitis and End-stage Renal disease: a prospective, multicenter, … Ended

2024-512470-10-00 End-stage Renal disease 11 2018-02-02
Adjuvant dendritic-cell immunotherapy plus temozolomide following surgery and chemoradiation in patients with newly diagnosed glioblastoma Ended

2024-515291-13-00 Glioblastoma grade IV 4 2016-04-01
Extended Criteria Treatment for Liver Metastases With Heavy Tumour Burden Halted

2024-512397-95-00 Colorectal Liver Metastases 4 2026-05-21
Mechanisms of Action of Paradoxical Responses to Zolpidem: A Multimodal Study Halted

2023-507404-31-03 Patients with acquired partial/total vision impairments 4 2025-02-11
PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy f… Halted

2023-506194-35-00 Colorectal liver metastases 5 2024-11-21
Efficacy of intradiscal injection of autologous BM-MSC in subjects with chronic LBP due to multilevel lumbar IDD Ended

2024-519112-14-00 low back pain 4 2025-02-13
DUET-study: A FEASIBILITY STUDY OF 177LU-PSMA RADIOLIGAND THERAPY ALTERNATED WITH RADIUM-223 IN PATIENTS WITH BONE-METASTATIC, OLIGO-METASTA… Ended

2024-518985-29-02 Prostate cancer 7 2024-11-21
PARADOX study Ended

2024-515278-28-00 ulcerative colitis 6 2024-11-15
CALCIGRAN FORTE AND DOSING OF IMMUNOSUPPRESSIVE DRUGS IN KIDNEY TRANSPLANT RECIPIENTS Ended

2024-515164-30-00 Kidney transplantation 6 2024-09-25
Optimization of the management of drepanocytosis patients treated with hydroxyurea: Interest of the pharmacological therapeutic follow-up Ended

2024-515562-14-00 Drepanocytosis 6 2024-07-19
PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITIS Ended

2023-509930-21-00 CKD 5, Peritoneal Dialysis 6 2024-05-01
Study of excretion of CORTICOSTEROIDS to improve their detection in Anti-doping controls. Ended

2023-508221-27-02 Healthy volunteers 3 2024-04-19
Physiologically based pharmacokinetic modelling of intravenous and intranasal formulations of naloxone in healthy volunteers Ended

2023-506064-14-00 Healthy volunteers 3 2024-03-05
First-in-human interleukin-15-transpresenting Wilms’ tumor protein 1-targeting autologous dendritic cell vaccination in cancer patients Ended

2024-515296-35-00 Histologically or cytologically confirmed solid tumor o 7 2023-12-06
Radiotherapy plus xevinapant or placebo in older patients with locally advanced head and neck cancer Ended

2022-502339-20-00 Squamous cell carcinoma of head and neck 4 2023-11-15
Routine versus selective protamine administration to reduce bleeding complications after transcatheter aortic valve implantation Ended

2023-504205-36-00 Aortic stenosis 11 2023-11-01
PREPARE-iVAC Ended

2023-503894-39-00 kidney transplantation 11 2023-08-22
CA-CIBLE : Impact of increasing the ionized serum calcium target post-filter on the effectiveness of regional citrate anticoagulation during… Ended

2024-511897-64-00 Adult patients hospitalized in intensive care with an i 11 2023-07-01
Pharmacokinetic study of minocycline in patients with nontuberculous mycobacterial disease Ended

2024-517758-87-00 Nontuberculous mycobacterial disease 2 2023-06-22
MERCURI-2 Ended

2024-515260-31-00 AKI 6 2023-06-09
REDUCE PMR: Rituximab Effect on Decreasing glUcoCorticoid Exposition in newly diagnosed PolyMyalgia Rheumatica Ended

2024-513544-28-00 Polymyalgia Rheumatica 6 2023-02-01
Treatment with Xeljanz in a population of patients with cutaneous T cell lymphoma Ended

2022-500599-79-00 Mycosis Fungoides 4 2023-01-10